MCID: PLM018
MIFTS: 39

Pulmonary Sclerosing Hemangioma malady

Categories: Cancer diseases, Respiratory diseases

Aliases & Classifications for Pulmonary Sclerosing Hemangioma

About this section

Aliases & Descriptions for Pulmonary Sclerosing Hemangioma:

Name: Pulmonary Sclerosing Hemangioma 11 39 13 68
 
Pneumocytoma 11

Classifications:



External Ids:

Disease Ontology11 DOID:5766
MeSH39 D047868
SNOMED-CT62 707365008
NCIt45 C5656

Summaries for Pulmonary Sclerosing Hemangioma

About this section
MalaCards based summary: Pulmonary Sclerosing Hemangioma, also known as pneumocytoma, is related to hemangioma and sclerosing hemangioma, and has symptoms including chest pain, coughing and hemoptysis. An important gene associated with Pulmonary Sclerosing Hemangioma is NKX2-1 (NK2 Homeobox 1), and among its related pathways are Coregulation of Androgen receptor activity and Arf6 trafficking events. Affiliated tissues include lung, bone and brain, and related mouse phenotypes are neoplasm and endocrine/exocrine gland.

Related Diseases for Pulmonary Sclerosing Hemangioma

About this section

Diseases related to Pulmonary Sclerosing Hemangioma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 92)
idRelated DiseaseScoreTop Affiliating Genes
1hemangioma10.6
2sclerosing hemangioma10.6
3adult teratoma10.4NKX2-1, SYP
4mast-cell sarcoma10.4NKX2-1, SYP
5bone remodeling disease10.4NKX2-1, SYP
6angora hair nevus10.4NKX2-1, SYP
7ovary mixed epithelial carcinoma10.4CHGA, SYP
8esophagus small cell carcinoma10.4CHGA, SYP
9lice infestation10.4CHGA, SYP
10childhood malignant schwannoma10.4CHGA, SYP
11microglandular adenosis of breast10.4CHGA, SYP
12clear cell adenoma10.4CHGA, SYP
13focal facial dermal dysplasia10.4CHGA, SYP
14osteoblastoma10.4CHGA, SYP
15esophagus adenocarcinoma10.4CHGA, SYP
16fraxf syndrome10.4CHGA, SYP
17froelich syndrome10.4CHGA, SYP
18mixed endometrial stromal and smooth muscle tumor10.4CHGA, SYP
19lumbar plexus neoplasm10.4CHGA, SYP
20cutaneous mastocytosis10.4CHGA, SYP
21pancreatic serous cystic neoplasm10.3CHGA, SYP
22pilocytic astrocytoma10.3CHGA, SYP
23subpulmonary stenosis10.3CHGA, SYP
24diencephalic astrocytomas10.3CHGA, SYP
25brain stem ependymoma10.3CHGA, SYP
26pseudounicornuate uterus10.3NKX2-1, SFTPB
27pneumonia10.3CHGA, SYP
28mesenchymoma10.3NKX2-1, SYP
29ovarian clear cell malignant adenofibroma10.3CHGA, SYP
30acanthoma10.3CHGA, SYP
31rectum signet ring adenocarcinoma10.3CHGA, SYP
32clear cell ependymoma10.3CHGA, SYP
33pancreatic agenesis10.3CHGA, SYP
34osteoarthritis10.3NKX2-1, SFTPB
35cranial nerve iii tumor10.3CHGA, SYP
36tricuspid valve stenosis10.3CHGA, SYP
37paranasal sinus cancer, adult10.3CHGA, SYP
38large intestine lipoma10.3CHGA, SYP
39mucinous adenocarcinoma10.3CHGA, SYP
40anal colloid adenocarcinoma10.3CHGA, SYP
41ferguson-smith tumor10.3CHGA, SYP
42carcinoma of the vocal tract10.3CHGA, SYP
43kummell's disease10.3CHGA, SYP
44papillary thymic adenocarcinoma10.3CHGA, SYP
45osteoclast-like giant cell neoplasm of the pancreas10.2CHGA, SYP
46synchronous bilateral breast carcinoma10.2CHGA, SYP
47mixed epithelial stromal tumour10.2CHGA, SYP
48epithelial predominant pulmonary blastoma10.2CTNNB1, SYP
49lung combined type small cell carcinoma10.2CHGA, SYP
50breast pericanalicular fibroadenoma10.2CHGA, SYP

Graphical network of the top 20 diseases related to Pulmonary Sclerosing Hemangioma:



Diseases related to pulmonary sclerosing hemangioma

Symptoms & Phenotypes for Pulmonary Sclerosing Hemangioma

About this section

UMLS symptoms related to Pulmonary Sclerosing Hemangioma:


chest pain, coughing, hemoptysis

MGI Mouse Phenotypes related to Pulmonary Sclerosing Hemangioma according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00020068.8AR, CTNNB1, CTNND1, NKX2-1
2MP:00053798.4AR, CHGA, CTNNB1, CTNND1, NKX2-1
3MP:00053678.0AR, CHGA, CTNNB1, CTNND1

Drugs & Therapeutics for Pulmonary Sclerosing Hemangioma

About this section

Drugs for Pulmonary Sclerosing Hemangioma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 34)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Doxorubicinapproved, investigationalPhase 3171423214-92-831703
Synonyms:
(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside
(8S-cis)-10-((3-amino-2,3,6-Trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
111266-55-8
14-Hydroxydaunomycin
14-Hydroxydaunorubicine
14-hydroxydaunomycin
14-hydroxydaunorubicine
23214-92-8
23257-17-2
24385-08-8
25311-50-6
25316-40-9
25316-40-9 (hydrochloride)
29042-30-6
AC1L1M5T
AC1Q29OJ
ADM
ADR
Adriablastin
Adriacin (hydrochloride salt)
Adriamycin
Adriamycin PFS
Adriamycin PFS (hydrochloride salt)
Adriamycin RDF
Adriamycin RDF (hydrochloride salt)
Adriamycin Semiquinone
Adriamycin semiquinone
Adriblas tina
Adriblastin
Adriblastina
Adriblastina (TN)
Adriblastina (hydrochloride salt)
Aerosolized Doxorubicin
BPBio1_000502
BRD-K92093830-003-04-3
BSPBio_000456
BSPBio_001031
C01661
C27H29NO11
CCRIS 739
CHEBI:28748
CHEMBL179
CID31703
Caelyx
Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74
Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120
D03899
DB00997
DM2
DOX-SL
Doxil
Doxo
Doxorubicin
Doxorubicin (USAN/INN)
Doxorubicin HCl
 
Doxorubicin Hydrochloride
Doxorubicin [USAN:INN:BAN]
Doxorubicin citrate
Doxorubicin hydrochloride (hydrochloride salt)
Doxorubicin-P4/D10
Doxorubicin-P4/D10 conjugate
Doxorubicin-hLL1
Doxorubicin-hLL1 conjugate
Doxorubicina
Doxorubicina [INN-Spanish]
Doxorubicine
Doxorubicine [INN-French]
Doxorubicinum
Doxorubicinum [INN-Latin]
EINECS 245-495-6
FI 106
Farmablastina (hydrochloride salt)
HMS2089H06
HSDB 3070
Hydroxydaunomycin hydrochlor ide (hydrochloride salt)
Hydroxydaunomycin hydrochloride (hydrochloride salt)
Hydroxydaunorubicin
Hydroxydaunorubicin hydrochloride (hydrochloride salt)
JT9100000
LMPK13050001
LS-1029
LS-165655
MLS000759533
Myocet
NCI-C01514
NChemBio.2007.10-comp13
NDC 38242-874
NIOSH/JT9100000
NSC 123127
Prestwick0_000438
Prestwick1_000438
Prestwick2_000438
Prestwick3_000438
Probes1_000151
Probes2_000129
RDF Rubex
Resmycin
Rubex
Rubex (hydrochloride salt)
SMP1_000106
SPBio_002395
TLC D-99
ThermoDox
Triferric doxorubicin
UNII-80168379AG
adiblastine (hydrochloride salt)
adr iablatina (hydrochloride salt)
adriablastine (hydrochloride salt)
adriablatina (hydrochloride salt)
adriblatina (hydrochloride salt)
doxorubicin
nchembio809-comp5
2
IfosfamideapprovedPhase 33913778-73-23690
Synonyms:
(+-)-Ifosfamid
(+-)-Ifosphamide
(+-)-Tetrahydro-N,3-bis(2-chloroethyl)-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
(D,L)-Ifosfamide
(R,S)-Ifosphamide
(R,S)-N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide
1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide
2,3-(N,N(sup 1)-Bis(2-chloroethyl)diamido)-1,3,2-oxazaphosphoridinoxyd
2,3-N,N(sup 1)-Bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxyd
2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis( 2-chloroethyl)tetrahydro-, 2-oxide
2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroethyl)tetrahydro-, 2-oxide
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide (8CI)
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide
3,} 2-oxazaphosphorine oxide
3-(2-Chloroethyl)-2-((2-chloroethyl)amino)perhydro-2H-1,3,2-oxazaphosphorine oxide
3-(2-Chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorine oxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorineoxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2- oxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide
36341-88-5
3778-73-2
84711-20-6
A 4942
AB00513932
AC-2113
AC1L1GHW
ASTA Z 4942
Ambap3778-73-2
Asta Z 4942
BPBio1_000865
BRN 0611835
BSPBio_000785
C07047
CAS-3778-73-2
CCRIS 352
CHEBI:5864
CHEMBL1024
CID3690
Cyfos
D00343
D007069
DB01181
EINECS 223-237-3
HMS1570H07
HMS2090M12
HMS2093N07
HSDB 7023
Holoxan
Holoxan 1000
I-Phosphamide
I06-0494
IFEX (TN)
Ifex
Ifosfamid
Ifosfamida
Ifosfamida [INN-Spanish]
Ifosfamide (JAN/USP/INN)
 
Ifosfamide Sterile
Ifosfamide [USAN:INN:BAN:JAN]
Ifosfamidum
Ifosfamidum [INN-Latin]
Ifosphamide
Ifsofamide
Iphosphamid
Iphosphamid(e)
Iphosphamide
Iso Endoxan
Iso-Endoxan
Isoendoxan
Isofosfamide
Isophosphamide
Isosfamide
LS-102
LS-99799
MJF 9325
MJF-9325
MLS002154021
Mitoxana
Mitoxana, Ifex, Ifosfamide
MolPort-003-666-704
N,3-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide
N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
N,N-Bis(beta-chloroethyl)-amino-N',O-propylene-phosphoric acid ester diamide
N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid
N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid [German]
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylen ephosphoric acid diamide
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylene phosphoric acid ester diamide
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid diamide
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid ester diamide
N-(2-Chloroethyl)-N-(3-(2-chloroethyl)-2-oxido-1,3,2-oxazaphosphinan-2-yl)amine
NCGC00016639-01
NCGC00179435-01
NCI-C01638
NCI60_000233
NPFAPI-04
NSC 109,724
NSC 109724
NSC-109,724
NSC-109724
NSC109,724
NSC109724
Naxamide
Prestwick0_000833
Prestwick1_000833
Prestwick2_000833
Prestwick3_000833
S1302_Selleck
SMR001233348
SPBio_002706
STL058690
UNII-UM20QQM95Y
WLN: T6NPOTJ AM2G BO B2G
Z 4942
Z-4942
Z4942
ifosfamide
isosfamide
{3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,
3
LenograstimapprovedPhase 31202135968-09-1
Synonyms:
G-CSF (CHO cell derived)
Glycosylated recombinant G-CSF
Glycosylated recombinant granulocyte colony stimulating factor
 
Granulocyte colony stimulating factor 3 (CHO cell derived)
Granulocyte colony-stimulating factor lenograstim
Lenograstim (genetical recombination)
Lenograstim rDNA
4
DoxilApproved June 1999Phase 3171431703
Synonyms:
Dox-SL
Doxil
 
Evacet
LipoDox
Pegylated Liposomal Doxorubicin Hydrochloride
liposomal doxorubicin
5Topoisomerase InhibitorsPhase 34945
6Alkylating AgentsPhase 34694
7Isophosphamide mustardPhase 3391
8Antineoplastic Agents, AlkylatingPhase 34474
9Anti-Bacterial AgentsPhase 310884
10Antibiotics, AntitubercularPhase 36972
11
IndinavirapprovedPhase 2110150378-17-95362440
Synonyms:
(1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-Pentonamide
(1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-pentonamide
(2S)-1-[(2S,4S)-4-benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide
150378-17-9
157810-81-6
157810-81-6 (sulfate (1:1) (salt))
166746-42-5
1c6y
1hsg
1hsh
1k6c
1sdt
1sdu
1sdv
1sgu
216884-06-9
2avo
2avs
2avv
2bpx
AC-20034
AC1L1U7I
AKOS000280989
BIDD:GT0378
BIDD:PXR0141
C07051
 
C36H47N5O4
CHEBI:44032
Compound J
Crixivan
Crixivan (TM)
DB00224
IDV
Indinavir (*1:1 Sulfate salt*)
Indinavir [USAN]
Indinavir anhydrous
Indinavir sulfate
Indinavir sulphate
Indinavir, Sulfate (1:1)
L 735524
L-735 524
L-735,524
L-735524
LS-173382
MK-639
MolPort-000-883-804
N-[2(R)-HYDROXY-1(S)-INDANYL]-5-[(2(S)-TERTIARY BUTYLAMINOCARBONYL)-4(3-PYRIDYLMETHYL)PIPERAZINO]-4(S)-HYDROXY-2(R)-PHENYLMETHYLPENTANAMIDE
NCGC00159460-02
NSC697197
Propolis & 4-Hydroxy-N-(2-hydroxy-2,3-dihydro-1H-1-indanyl)-N'-(1,1-dimethylethyl)-2-phenylmethyl-5-[4-(3-pyridylmethyl)-1-piperzinyl]hexanediamide
Propolis+Indinavir
RS-253
UNII-9MG78X43ZT
indinavir
12
Ritonavirapproved, investigationalPhase 2870155213-67-5392622
Synonyms:
1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate
155213-67-5
1hxw
1sh9
5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S)-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate
5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate
538, ABT
A-84538
ABBOTT-84538
ABT 538
ABT 84538
ABT-538
ABT538
AC-733
AC1L94GB
AKOS000280930
Abbott 84538
BIDD:GT0387
BIDD:PXR0023
Bio-0093
C07240
C37H48N6O5S2
CHEBI:45409
CHEMBL163
CID392622
CPD000466395
D00427
D019438
 
DB00503
DRG-0244
FT-0082824
HMS2051B08
HSDB 7160
LS-148860
MLS000759541
MLS001424063
MolPort-000-883-877
N-[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl]-N~2~-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-L-valinamide
NCGC00159462-02
NSC693184
Norvir
Norvir (TM)
Norvir (TN)
Norvir Sec
RIT
RTV
Ritonavir
Ritonavir (JAN/USAN/INN)
Ritonavir [USAN]
Ritonavir is an inhibitor of HIV protease used to treat HIV infection and AIDS.
Ritonavirum
S1185_Selleck
SAM001246783
SMR000466395
STK634209
ZINC03944422
ritonavir
13HIV Protease InhibitorsPhase 25319
14
protease inhibitorsPhase 25320
Synonyms:
 
protease inhibitors
15Liver ExtractsPhase 23868
16Cytochrome P-450 Enzyme InhibitorsPhase 23822
17Anti-HIV AgentsPhase 23100
18Cytochrome P-450 CYP3A InhibitorsPhase 21666
19Anti-Retroviral AgentsPhase 23232
20Anti-Infective AgentsPhase 221402
21Antiviral AgentsPhase 29732
22ColaNutraceuticalPhase 2, Phase 11881
23
Belinostatapproved, investigationalPhase 142866323-14-0
Synonyms:
 
Belinostat
PXD 101
24
FluorouracilapprovedPhase 1179151-21-83385
Synonyms:
1-fluoro-1h-pyrimidine-2,4-dione
1004-03-1
1upf
2,4-Dihydroxy-5-fluoropyrimidine
2,4-Dioxo-5-fluoropryimidine
2,4-Dioxo-5-fluoropyrimidine
47576_FLUKA
4921-97-5
5 FU Lederle
5 FU medac
5 Fluorouracil
5 Fluorouracil biosyn
5 HU Hexal
5-FU
5-FU (TN)
5-FU Lederle
5-FU medac
5-Faracil
5-Fluor-2,4(1H,3H)-pyrimidindion
5-Fluor-2,4(1H,3H)-pyrimidindion [Czech]
5-Fluor-2,4-dihydroxypyrimidin
5-Fluor-2,4-dihydroxypyrimidin [Czech]
5-Fluor-2,4-pyrimidindiol
5-Fluor-2,4-pyrimidindiol [Czech]
5-Fluoracil
5-Fluoracil [German]
5-Fluoracyl
5-Fluoro-2,4(1H,3H)-pyrimidinedione
5-Fluoro-2,4-pyrimidinedione
5-Fluoropyrimidin-2,4-diol
5-Fluoropyrimidine-2,4-dione
5-Fluorouracil
5-Fluorouracil-biosyn
5-Fluoruracil
5-Fluoruracil [German]
5-Fluracil
5-Ftouracyl
5-HU Hexal
5-fluoro uracil
5-fluoro-1H-pyrimidine-2,4-dione
5-fluoropyrimidine-2,4(1H,3H)-dione
5-fluorouracil
51-21-8
5FU
79108-01-3
AC-11201
AC1L1FTE
AC1Q4N2X
AI3-25297
AKOS000119162
AKOS003237897
AccuSite
Actino-Hermal
Adrucil
Adrucil (TN)
Allergan Brand of Fluorouracil
Arumel
BB_NC-0576
BSPBio_002048
C07649
C4H3FN2O2
CCRIS 2582
CHEBI:46345
CHEMBL185
CID3385
CPD0-1327
CPD000038082
CSP Brand of Fluorouracil
Carac
Carac (TN)
Carzonal
Cinco FU
Cytosafe
D005472
D00584
DB00544
Dakota Brand of Fluorouracil
Dakota, Fluorouracile
Dermatech Brand of Fluorouracil
Dermik Brand of Fluorouracil
DivK1c_000054
EINECS 200-085-6
EU-0100536
Effluderm
Effluderm (free base)
Efudex
Efudix
Efurix
F 6627
F0151
F6627_SIGMA
F8423_SIGMA
FT-0082524
FU
Ferrer Brand of Fluorouracil
Fiverocil
Fluoro Uracil
Fluoro Uracile ICN
Fluoro-Uracile ICN
Fluoro-uracile
Fluoro-uracilo
Fluoroblastin
Fluoroplex
Fluoroplex (TN)
Fluorouracil
Fluorouracil (JP15/USP/INN)
Fluorouracil GRY
Fluorouracil Mononitrate
Fluorouracil Monopotassium Salt
Fluorouracil Monosodium Salt
Fluorouracil Potassium Salt
Fluorouracil Teva Brand
Fluorouracil [USAN:INN:BAN:JAN]
 
Fluorouracil-GRY
Fluorouracile
Fluorouracile Dakota
Fluorouracile [DCIT]
Fluorouracilo
Fluorouracilo Ferrer Far
Fluorouracilo [INN-Spanish]
Fluorouracilum
Fluorouracilum [INN-Latin]
Fluoruracil
Fluouracil
Flurablastin
Fluracedyl
Fluracil
Fluracilum
Fluri
Fluril
Fluro Uracil
Fluroblastin
Flurodex
Flurouracil
Flurox
Ftoruracil
Gry Brand of Fluorouracil
HMS1920O18
HMS2090I04
HMS2091F19
HMS500C16
HSDB 3228
Haemato Brand of Fluorouracil
Haemato fu
Haemato-fu
Hexal Brand of Fluorouracil
I07-0022
ICN Brand of Fluorouracil
IDI1_000054
IN1335
KBio1_000054
KBio2_001321
KBio2_003889
KBio2_006457
KBio3_001268
KBioGR_001253
KBioSS_001321
Kecimeton
LS-153
Lopac-F-6627
Lopac0_000536
MLS000069498
MLS002415705
MolPort-000-156-102
MolPort-003-990-447
MolPort-004-758-143
MolPort-004-758-144
MolPort-005-861-486
NCGC00015442-01
NCGC00015442-03
NCGC00015442-10
NCGC00091349-01
NCGC00091349-02
NCGC00091349-03
NCGC00091349-04
NCGC00091349-05
NCGC00091349-07
NCGC00091349-08
NCI60_001652
NINDS_000054
NSC 19893
NSC-19893
NSC19893
Neocorp Brand of Fluorouracil
Neofluor
Onkofluor
Onkoworks Brand of Fluorouracil
Phthoruracil
Phtoruracil
Queroplex
Ribofluor
Riemser Brand of Fluorouracil
Ro 2-9757
Ro-2-9757
Roche Brand of Fluorouracil
S1209_Selleck
SAM002264615
SMR000038082
SPBio_000291
SPECTRUM1500305
STK297802
Spectrum2_000076
Spectrum3_000434
Spectrum4_000557
Spectrum5_000718
Spectrum_000841
T5233394
TL8006093
Teva Brand of Fluorouracil
Timazin
U 8953
U-8953
UNII-U3P01618RT
UPCMLD-DP130
UPCMLD-DP130:001
URF
Ulup
WLN: T6MVMVJ EF
ZINC00897110
biosyn Brand of Fluorouracil
fluorouracil
inhibits thymilidate synthetase
medac Brand of Fluorouracil
nchembio.90-comp3
nchembio809-comp6
ribosepharm Brand of Fluorouracil
tetratogen
25Analgesics, Non-NarcoticPhase 16260
26Interleukin-2Phase 1553
27VaccinesPhase 16428
28AnalgesicsPhase 111287
29Peripheral Nervous System AgentsPhase 122776
30Antimetabolites, AntineoplasticPhase 17171
31AndrogensPhase 11275
32AntimetabolitesPhase 111774
33Histone Deacetylase InhibitorsPhase 1566
34Immunosuppressive AgentsPhase 112770

Interventional clinical trials:

idNameStatusNCT IDPhase
1Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue SarcomaCompletedNCT00002764Phase 3
2External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain MetastasesUnknown statusNCT00637637Phase 2
3Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the LungCompletedNCT00503295Phase 2
4Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic SarcomaSuspendedNCT02601209Phase 1, Phase 2
5Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid TumorsCompletedNCT00413322Phase 1
6Vaccine Therapy in Treating Patients With Metastatic CancerCompletedNCT00020267Phase 1

Search NIH Clinical Center for Pulmonary Sclerosing Hemangioma


Cochrane evidence based reviews: pulmonary sclerosing hemangioma

Genetic Tests for Pulmonary Sclerosing Hemangioma

About this section

Anatomical Context for Pulmonary Sclerosing Hemangioma

About this section

MalaCards organs/tissues related to Pulmonary Sclerosing Hemangioma:

36
Lung, Bone, Brain, Liver, Thyroid, Lymph node, Fetal lung

Publications for Pulmonary Sclerosing Hemangioma

About this section

Articles related to Pulmonary Sclerosing Hemangioma:

(show top 50)    (show all 60)
idTitleAuthorsYear
1
Co-occurrence of bronchial papilloma and pulmonary sclerosing hemangioma in a male. (27812454)
2016
2
Preoperative Diagnosis in 46 Cases of Pulmonary Sclerosing Hemangioma. (27231179)
2016
3
Bone metastasis in pulmonary sclerosing hemangioma. (26552471)
2015
4
Pulmonary sclerosing hemangioma with lymph node metastasis: A case report and literature review. (24944657)
2014
5
A rare tumor of the lung: pulmonary sclerosing hemangioma (pneumocytoma). (23290153)
2013
6
Pulmonary sclerosing hemangioma: a unique epithelial neoplasm of the lung (report of 26 cases). (23587094)
2013
7
Unusual coexistence of pulmonary sclerosing hemangioma and pericardial cyst. (24887810)
2013
8
18F-FDG PET/CT features of pulmonary sclerosing hemangioma. (22291338)
2013
9
Synchronous occurrence of breast cancer and pulmonary sclerosing hemangioma: management and review of the literature. (23838116)
2013
10
Histogenesis of pulmonary sclerosing hemangioma and significance of P63 expression. (23910931)
2013
11
Pulmonary sclerosing hemangioma: report of two cases. (22943472)
2012
12
In pulmonary sclerosing hemangioma expression of I^-catenin, Axin, and C-myc differs between the two cell types. (22614067)
2012
13
A case of pulmonary sclerosing hemangioma with low (18)FDG uptake in PET. (22740968)
2012
14
Pulmonary sclerosing hemangioma presenting with dense spindle stroma cells: a potential diagnostic pitfall. (23227905)
2012
15
Pulmonary sclerosing hemangioma: pitfalls in management. (21471259)
2011
16
Pulmonary sclerosing hemangioma in a 21-year-old male with metastatic hereditary non-polyposis colorectal cancer: report of a case. (21645337)
2011
17
F-18 FDG PET/CT in evaluation of pulmonary sclerosing hemangioma. (21467848)
2011
18
Pulmonary sclerosing hemangioma with pleural dissemination: report of a case. (21264765)
2011
19
Comparison of genetic and epigenetic alterations at 11 tumor suppressor loci in pulmonary sclerosing hemangioma and adenocarcinoma. (21649526)
2011
20
A case of pulmonary sclerosing hemangioma surrounded by giant cystic change on high-resolution computed tomography. (20634757)
2011
21
Determination of clonal status of pulmonary sclerosing hemangioma with X-chromosome inactivation mosaicism and polymorphism of phosphoglycerate kinase and androgen receptor genes. (20422318)
2011
22
Coexistence of pulmonary sclerosing hemangioma and primary adenocarcinoma in the same nodule of lung. (21599956)
2011
23
Surgery for Pulmonary Sclerosing Hemangioma: Lobectomy versus Limited Resection. (22263122)
2011
24
Large masses with diffuse calcification: pulmonary sclerosing hemangioma. (20732478)
2010
25
Cytogenetic study of a pulmonary sclerosing hemangioma. (19837274)
2009
26
Recurrence of pulmonary sclerosing hemangioma. (18278694)
2008
27
Pulmonary sclerosing hemangioma manifesting as a nodule with irregular air clefts on high-resolution CT. (17579131)
2007
28
Expression of E-cadherin, beta-catenin and p120ctn in the pulmonary sclerosing hemangioma. (17383052)
2007
29
Increased expression of matrix metalloproteinase 9 and tubulin-alpha in pulmonary sclerosing hemangioma. (17914564)
2007
30
Pulmonary sclerosing hemangioma detected by fluorodeoxyglucose positron emission tomography in familial adenomatous polyposis: report of a case. (17473941)
2007
31
Gene expression and clonality analysis of the androgen receptor and phosphoglycerate kinase genes in polygonal cells and cuboidal cells in so-called pulmonary sclerosing hemangioma. (17873892)
2007
32
Study of androgen receptor and phosphoglycerate kinase gene polymorphism in major cellular components of the so-called pulmonary sclerosing hemangioma]. (16776996)
2006
33
Pulmonary sclerosing hemangioma presenting as solitary pulmonary nodule: dynamic CT findings and histopathologic comparisons. (16861548)
2006
34
Pulmonary sclerosing hemangioma with pulmonary metastasis. (16902885)
2006
35
Proteomic analysis of pulmonary sclerosing hemangioma. (16892484)
2006
36
Pulmonary sclerosing hemangioma with metastasis to the mediastinal lymph node. (16305908)
2005
37
Expression of the estrogen receptor beta in 37 surgically treated pulmonary sclerosing hemangiomas in comparison with non-small cell lung carcinomas. (16226111)
2005
38
Bilateral multiple pulmonary sclerosing hemangioma. (15828298)
2005
39
Expression patterns of markers for type II pneumocytes in pulmonary sclerosing hemangiomas and fetal lung tissues. (15974816)
2005
40
Clinicopathological analysis of pulmonary sclerosing hemangioma. (15561002)
2004
41
Type-II pneumocyte differentiation in pulmonary sclerosing hemangioma: ultrastructural differentiation and immunohistochemical distribution of lineage-specific transcription factors (TTF-1, HNF-3 alpha, and HNF-3 beta) and surfactant proteins. (15138814)
2004
42
Immunohistochemical and ultrastructural markers suggest different origins for cuboidal and polygonal cells in pulmonary sclerosing hemangioma. (15116333)
2004
43
Pulmonary sclerosing hemangioma associated with familial adenomatous polyposis. (15188145)
2004
44
Pulmonary sclerosing hemangioma with lymph node metastases. (14571291)
2003
45
Pulmonary sclerosing hemangioma with lymph node metastases: report of 4 cases. (12653576)
2003
46
Biologic significance of thyroid transcription factor-1 and surfactant protein expression in pulmonary sclerosing hemangioma]. (14720435)
2003
47
Cytopathologic diagnosis of pulmonary sclerosing hemangioma. (11892021)
2002
48
Imprint cytologic features of pulmonary sclerosing hemangioma: comparison with well-differentiated papillary adenocarcinoma. (12115302)
2002
49
The expression of thyroid transcription factor-1 in pulmonary sclerosing hemangioma and a further investigation on histogenesis of the tumor]. (11955335)
2002
50
A critical examination of the immunophenotype of pulmonary sclerosing hemangioma. (10716159)
2000

Variations for Pulmonary Sclerosing Hemangioma

About this section

Expression for genes affiliated with Pulmonary Sclerosing Hemangioma

About this section
Search GEO for disease gene expression data for Pulmonary Sclerosing Hemangioma.

Pathways for genes affiliated with Pulmonary Sclerosing Hemangioma

About this section

GO Terms for genes affiliated with Pulmonary Sclerosing Hemangioma

About this section

Cellular components related to Pulmonary Sclerosing Hemangioma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1synapseGO:00452028.6CTNNB1, CTNND1, SYP

Biological processes related to Pulmonary Sclerosing Hemangioma according to GeneCards Suite gene sharing:

(show all 8)
idNameGO IDScoreTop Affiliating Genes
1Leydig cell differentiationGO:003332710.2AR, NKX2-1
2epithelial tube branching involved in lung morphogenesisGO:00604419.9CTNNB1, NKX2-1
3androgen receptor signaling pathwayGO:00305219.8AR, CTNNB1
4cellular processGO:00099879.8AR, CTNNB1
5epithelial cell differentiation involved in prostate gland developmentGO:00607429.8AR, CTNNB1
6negative regulation of neuron deathGO:19012159.8CHGA, CTNNB1
7adherens junction organizationGO:00343329.7CTNNB1, CTNND1
8positive regulation of gene expressionGO:00106288.8AR, CTNNB1, NKX2-1

Molecular functions related to Pulmonary Sclerosing Hemangioma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1RNA polymerase II transcription factor bindingGO:00010859.7AR, CTNNB1
2cadherin bindingGO:00452969.7CTNNB1, CTNND1
3enzyme bindingGO:00198999.4AR, CTNNB1, NKX2-1
4transcription regulatory region DNA bindingGO:00442128.8AR, CTNNB1, NKX2-1

Sources for Pulmonary Sclerosing Hemangioma

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet